Review Article
Current Concepts of Neurodegenerative Mechanisms in Alzheimer’s Disease
Table 1
Evidence of inflammatory mediators reported in AD.
| Inflammatory mediator | Changes reported | Human site | References |
| Tumour necrosis factor-α (TNF-α) | ↑ | Serum | [52] | ↑ | Brain | | ↑ | Brain | | ↑ | Blood | |
| Interleukin-6 (IL-6) | ↑ | Serum | [53] | ↑ | Brain | [54] | ↑ | Serum | [55] | ↑ | CSF | |
| Interleukin-1β (IL-1β) | ↑ | Brain | [56] | ↑ | Blood | [55] | ↑ | CSF | |
| Cyclooxygenase-2 (COX-2) | ↑ | Neurons | [57] |
| Interleukin-2 (IL-2) | ↑ | Serum | [55] | ↑ | CSF | |
| Monocyte chemotactic protein (MCP-1) | ↑ | Brain | [52] | ↑ | Blood | |
| Caspase-8 | ↑ | Neurons | [57] | ↑ | Microglia | [58] |
| Caspase-3/7 | ↑ | Microglia | [58] |
| Transforming growth factor (TGF) β1 | ↑ | CSF | [59] |
| Transforming growth factor (TGF) β2 | ↑ | CSF | [59] |
|
|